Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer

Clinical trial NCT02530008 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02530008
Sponsor: Abramson Cancer Center at Penn Medicine
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Women With Suspected or Confirmed Recurrent Breast Cancer

Start date: 2013-10-01
Primary completion: 2024-10-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.